- AYTU Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Aytu BioPharma (AYTU) CORRESPCorrespondence with SEC
Filed: 7 Jan 20, 12:00am
January 7, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Aytu BioScience, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-235548)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-3 (File No. 333-235548) be accelerated so that it will be declared effective at 4:00PM EST on Friday, January 10, 2020 or as soon thereafter as is practicable.
Very truly yours, | ||
Aytu BioScience, Inc. | ||
By: | /s/ Joshua Disbrow | |
Name: | Joshua Disbrow | |
Title: | Chief Executive Officer |